Harrow (HROW) Net Cash Flow (2010 - 2026)
Harrow's (HROW) quarterly Net Cash Flow came in at $21.7 million in Q1 2026, up 11.49% year-on-year from $19.5 million in Q1 2025, and up 1693.32% quarter-over-quarter from -$1.4 million in Q4 2025.
Harrow (HROW) Net Cash Flow (2010 - 2026) Analysis & Trends
Harrow's Net Cash Flow history runs 17 years deep, the most recent figure standing at $21.7 million for Q1 2026.
- On a quarterly basis, Net Cash Flow rose 11.49% year-over-year to $21.7 million in Q1 2026; TTM through Mar 2026 was $27.9 million, a 1640.73% increase from a year earlier, with the FY2025 full-year figure at $25.7 million, up 195.69% from the prior year.
- Net Cash Flow improved to $21.7 million in Q1 2026 per HROW's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $51.3 million in Q4 2022 and bottomed at -$77.0 million in Q1 2023.
- The 5-year median for Net Cash Flow is $2.4 million (2024), against an average of $3.1 million.
- Biggest YoY gain for Net Cash Flow was 2997.63% in 2023; the steepest drop was 35069.86% in 2023.
- Year by year, Net Cash Flow stood at $51.3 million in 2022, then sank by 83.48% to $8.5 million in 2023, then tumbled by 399.16% to -$25.4 million in 2024, then surged by 94.62% to -$1.4 million in 2025, then surged by 1693.32% to $21.7 million in 2026.
- Per Business Quant, the three latest HROW Net Cash Flow figures stand at $21.7 million (Q1 2026), -$1.4 million (Q4 2025), and $21.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.72 Mn |
| Mar 31, 2026 | 21.72 Mn |
| Dec 31, 2025 | -1.36 Mn |
| Dec 31, 2025 | -1.36 Mn |
| Sep 30, 2025 | 21.33 Mn |
| Sep 30, 2025 | 21.33 Mn |
| Jun 30, 2025 | -13.76 Mn |
| Jun 30, 2025 | -13.76 Mn |
| Mar 31, 2025 | 19.48 Mn |
| Mar 31, 2025 | 19.48 Mn |
| Dec 31, 2024 | -25.35 Mn |
| Dec 31, 2024 | -25.35 Mn |
| Sep 30, 2024 | 1.63 Mn |
| Sep 30, 2024 | 1.63 Mn |
| Jun 30, 2024 | 2.43 Mn |
| Jun 30, 2024 | 2.43 Mn |
| Mar 31, 2024 | -5.55 Mn |
| Mar 31, 2024 | -5.55 Mn |
| Dec 31, 2023 | 8.48 Mn |
| Dec 31, 2023 | 8.48 Mn |